chr9-135786170-C-CGCCCT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2

The NM_020822.3(KCNT1):​c.3178-7_3178-3dupTGCCC variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 3 hom., cov: 0)
Exomes 𝑓: 0.0063 ( 23 hom. )

Consequence

KCNT1
NM_020822.3 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.600

Publications

1 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
BP6
Variant 9-135786170-C-CGCCCT is Benign according to our data. Variant chr9-135786170-C-CGCCCT is described in ClinVar as Benign. ClinVar VariationId is 196185.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00574 (865/150638) while in subpopulation AMR AF = 0.00868 (132/15210). AF 95% confidence interval is 0.00747. There are 3 homozygotes in GnomAd4. There are 411 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 865 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNT1NM_020822.3 linkc.3178-7_3178-3dupTGCCC splice_acceptor_variant, intron_variant Intron 28 of 30 ENST00000371757.7 NP_065873.2 Q5JUK3-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNT1ENST00000371757.7 linkc.3178-7_3178-3dupTGCCC splice_acceptor_variant, intron_variant Intron 28 of 30 1 NM_020822.3 ENSP00000360822.2 Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.00575
AC:
865
AN:
150524
Hom.:
3
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00335
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00869
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00413
Gnomad SAS
AF:
0.00253
Gnomad FIN
AF:
0.00315
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00736
Gnomad OTH
AF:
0.00727
GnomAD2 exomes
AF:
0.00488
AC:
962
AN:
197052
AF XY:
0.00464
show subpopulations
Gnomad AFR exome
AF:
0.00330
Gnomad AMR exome
AF:
0.00619
Gnomad ASJ exome
AF:
0.00331
Gnomad EAS exome
AF:
0.00414
Gnomad FIN exome
AF:
0.00274
Gnomad NFE exome
AF:
0.00601
Gnomad OTH exome
AF:
0.00593
GnomAD4 exome
AF:
0.00634
AC:
8863
AN:
1397248
Hom.:
23
Cov.:
12
AF XY:
0.00629
AC XY:
4377
AN XY:
696296
show subpopulations
African (AFR)
AF:
0.00324
AC:
99
AN:
30558
American (AMR)
AF:
0.00708
AC:
275
AN:
38858
Ashkenazi Jewish (ASJ)
AF:
0.00350
AC:
88
AN:
25144
East Asian (EAS)
AF:
0.00417
AC:
161
AN:
38610
South Asian (SAS)
AF:
0.00314
AC:
257
AN:
81932
European-Finnish (FIN)
AF:
0.00333
AC:
168
AN:
50462
Middle Eastern (MID)
AF:
0.00322
AC:
18
AN:
5596
European-Non Finnish (NFE)
AF:
0.00695
AC:
7428
AN:
1068114
Other (OTH)
AF:
0.00636
AC:
369
AN:
57974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
388
776
1164
1552
1940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00574
AC:
865
AN:
150638
Hom.:
3
Cov.:
0
AF XY:
0.00559
AC XY:
411
AN XY:
73584
show subpopulations
African (AFR)
AF:
0.00334
AC:
136
AN:
40752
American (AMR)
AF:
0.00868
AC:
132
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3466
East Asian (EAS)
AF:
0.00414
AC:
21
AN:
5068
South Asian (SAS)
AF:
0.00253
AC:
12
AN:
4744
European-Finnish (FIN)
AF:
0.00315
AC:
33
AN:
10470
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00736
AC:
498
AN:
67646
Other (OTH)
AF:
0.00719
AC:
15
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
40
80
119
159
199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00360
Hom.:
365
Bravo
AF:
0.00608

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 31, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Jul 19, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 14 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.60
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757968008; hg19: chr9-138678016; API